In Brief This Week: Danaher, SeqLL, Yourgene Health, Thermo Fisher, Caribou Bio, More
News items for the week of Aug. 30, 2021.
Caribou Biosciences Files for $100M IPO
The company plans to use the proceeds from the filing to advance the development of its drug candidates and genome editing technologies.
Oxford Nanopore Licenses CRISPR-Cas9 IP From Caribou Biosciences for Targeted Nanopore Sequencing
The firm said CRISPR will enable targeted sequencing of long regions of interest that were previously only accessible with long-read whole-genome sequencing.
CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles
As MPEG LA tries to complete its larger CRISPR IP patent pool, smaller license agreements continue and a mini-pool has emerged between key players.
CRISPR technology has made its way around the world, but in the wake of the He Jiankui controversy, the industry is asking what recourse it has against misuse.
May 16, 2016
Caribou Biosciences Raises $30M in Series B Funding
Feb 23, 2016